Fermenta Biotech [FERMENTA] vs Sun Pharma Advanced [SPARC] Detailed Stock Comparison

Fermenta Biotech Ltd.

BSE
Loading...

Sun Pharma Advanced Research Company Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Fermenta Biotech Ltd. wins in 15 metrics, Sun Pharma Advanced Research Company Ltd. wins in 3 metrics, with 0 ties. Fermenta Biotech Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Fermenta Biotech Ltd. Sun Pharma Advanced Research Company Ltd. Better
P/E Ratio (TTM) 10.85 -13.65 Fermenta Biotech Ltd.
Price-to-Book Ratio 2.40 -13.55 Fermenta Biotech Ltd.
Debt-to-Equity Ratio 29.03 -1.21 Fermenta Biotech Ltd.
PEG Ratio -0.17 -11.15 Fermenta Biotech Ltd.
EV/EBITDA 8.13 -22.27 Fermenta Biotech Ltd.
Profit Margin (TTM) 16.00% -53.22% Fermenta Biotech Ltd.
Operating Margin (TTM) 14.26% -700.71% Fermenta Biotech Ltd.
EBITDA Margin (TTM) 14.26% N/A N/A
Return on Equity 21.44% 157.88% Sun Pharma Advanced Research Company Ltd.
Return on Assets (TTM) 12.51% -102.08% Fermenta Biotech Ltd.
Free Cash Flow (TTM) $187.69M $-3.71B Fermenta Biotech Ltd.
Dividend Yield 0.71% N/A N/A
1-Year Return -5.37% 14.56% Sun Pharma Advanced Research Company Ltd.
Price-to-Sales Ratio (TTM) 1.71 87.98 Fermenta Biotech Ltd.
Enterprise Value $9.90B $50.87B Sun Pharma Advanced Research Company Ltd.
EV/Revenue Ratio 1.82 95.73 Fermenta Biotech Ltd.
Gross Profit Margin (TTM) 62.42% -59.53% Fermenta Biotech Ltd.
Revenue per Share (TTM) $186 $2 Fermenta Biotech Ltd.
Earnings per Share (Diluted) $29.63 $-8.25 Fermenta Biotech Ltd.
Beta (Stock Volatility) -0.13 0.19 Fermenta Biotech Ltd.

Fermenta Biotech Ltd. vs Sun Pharma Advanced Research Company Ltd. Stock Performance Analysis

Loading Price Chart...

FERMENTA
SPARC

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Fermenta Biotech Ltd.0.80%8.12%5.90%0.46%17.65%-9.36%
Sun Pharma Advanced Research Company Ltd.2.14%-5.81%49.25%68.87%37.58%54.41%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Fermenta Biotech Ltd.-5.37%110.03%-8.87%55.86%55.86%55.86%
Sun Pharma Advanced Research Company Ltd.14.56%13.10%-5.14%-23.02%148.11%-27.03%

Performance & Financial Health Analysis: Fermenta Biotech Ltd. vs Sun Pharma Advanced Research Company Ltd.

MetricFERMENTASPARC
Market Information
Market Cap i₹9.28B₹46.75B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i14,0402,401,062
90 Day Avg. Volume i18,7962,083,443
Last Close₹319.55₹212.97
52 Week Range₹256.40 - ₹399.00₹108.00 - ₹248.75
% from 52W High-19.91%-14.38%
All-Time High₹449.00 (Feb 10, 2025)₹875.00 (Apr 24, 2006)
% from All-Time High-28.83%-75.66%
Growth Metrics
Quarterly Revenue Growth-0.12%-0.43%
Quarterly Earnings Growth-0.66%-0.43%
Financial Health
Profit Margin (TTM) i0.16%-0.53%
Operating Margin (TTM) i0.14%-7.01%
Return on Equity (TTM) i0.21%1.58%
Debt to Equity (MRQ) i29.03-1.21
Cash & Liquidity
Book Value per Share (MRQ)₹134.13₹-10.63
Cash per Share (MRQ)₹17.83₹0.03
Operating Cash Flow (TTM) i₹-59,490,000₹-3,484,287,000
Levered Free Cash Flow (TTM) i₹768.62M₹-3,425,094,000
Dividends
Last 12-Month Dividend Yield i0.71%N/A
Last 12-Month Dividend i₹2.50N/A

Valuation & Enterprise Metrics Analysis: Fermenta Biotech Ltd. vs Sun Pharma Advanced Research Company Ltd.

MetricFERMENTA (Apr 24, 2026)SPARC (Apr 22, 2026)
Price Ratios
P/E Ratio (TTM) i10.85-13.65
Forward P/E iN/A2.60
PEG Ratio i-0.17-11.15
Price to Sales (TTM) i1.7187.98
Price to Book (MRQ) i2.40-13.55
Market Capitalization
Market Capitalization i₹9.28B₹46.75B
Enterprise Value i₹9.90B₹50.87B
Enterprise Value Metrics
Enterprise to Revenue i1.8295.73
Enterprise to EBITDA i8.13-22.27
Risk & Other Metrics
Beta i-0.130.19
Book Value per Share (MRQ) i₹134.13₹-10.63

Financial Statements Comparison: Fermenta Biotech Ltd. vs Sun Pharma Advanced Research Company Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricFERMENTA (2025)SPARC (2025)
Revenue/Sales i4.67B717.66M
Cost of Goods Sold i1.63B1.10B
COGS % of Revenue i35.0%153.2%
Gross Profit i3.04B-381.94M
Gross Margin i65.0%-53.2%
Research & Development iN/AN/A
Operating Income (EBIT) i933.53M-3.34B
Operating Margin i20.0%-465.5%
EBITDA i1.24B-3.23B
EBITDA Margin i26.6%-450.0%
Pre-Tax Income i832.08M-3.43B
Pre-Tax Income % of Revenue i17.8%-477.6%
Income Tax i68.05M-2.72M
Income Tax % of Revenue i1.5%-0.4%
Net Income (Profit) i764.03M-3.43B
Profit Margin i16.4%-477.3%

Balance Sheet & Liquidity Metrics

MetricFERMENTA (2025)SPARC (2025)
Cash & Equivalents i282.40M19.64M
Total Current Assets i3.35B261.97M
Total Current Assets % of Revenue i71.8%36.5%
Total Current Liabilities i2.12B3.74B
Total Current Liabilities % of Revenue i45.4%521.5%
Long-Term Debt i194.91M1.07B
Long-Term Debt % of Revenue i4.2%149.0%
Total Shareholders Equity i3.59B-2.17B
Retained Earnings i3.25B-23.22B
Retained Earnings % of Revenue i69.7%-3,235.0%
Property, Plant & Equipment i2.16B178.02M

Cash Flow Statement Comparison

MetricFERMENTA (2025)SPARC (2025)
Operating Cash Flow i-59.49M-3.48B
Operating Cash Flow % of Revenue i-1.3%-485.5%
Capital Expenditures i-28.82M-97.45M
Free Cash Flow i187.69M-3.71B
FCF Margin i4.0%-516.4%
Debt Repayment i-358.24M-3.69B
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricFERMENTASPARC
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i28.87M324.52M
Float Shares i8.42M91.32M
% Held by Insiders i71.66%72.96%
% Held by Institutions i0.00%2.56%
% Held by Public i28.34%24.48%

Dividend Analysis & Yield Comparison: Fermenta Biotech Ltd. vs Sun Pharma Advanced Research Company Ltd.

MetricFERMENTASPARC
Last 12-Month Dividend i₹2.50N/A
Last 12-Month Dividend Yield i0.71%N/A
3-Year Avg Annual Dividend i₹0.83N/A
3-Year Avg Dividend Yield i0.71%N/A
3-Year Total Dividends i₹2.50N/A
Ex-Dividend DateAug 06, 2025N/A